CAS 1642303-38-5

ITI-214

CAS: 1642303-38-5

ITI-214 is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members, exhibits potent PDE1 inhibitory activity.

Formula: C₂₉H₂₉FN₇O₅P

Purity: 98.21%

Color and Shape: Solid

Molecular weight: 605.56

Ref: TM-T11689

ITI-214

CAS: 1642303-38-5

ITI-214

Formula: C₂₉H₂₉FN₇O₅P

Purity: ≥98%

Molecular weight: 605.56

Ref: 54-BUP05064

ITI-214

CAS: 1642303-38-5

(6AR,9aS)-2-(4-(6-fluoropyridin-2-yl)benzyl)-5-methyl-3-(phenylamino)-5,6a,7,8,9,9a-hexahydrocyclopenta[4,5]imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(2H)-one phosphate

Formula: C₂₉H₂₉FN₇O₅P

Purity: 98+%

Molecular weight: 605.56

Ref: IN-DG630414

ITI-214 phosphate

Controlled Product

CAS: 1642303-38-5

ITI-214 is a novel non-steroidal anti-inflammatory drug (NSAID) that has been shown to have potent anti-inflammatory and analgesic effects in animal models. ITI-214 targets phosphodiesterases, which are enzymes that break down the signaling molecule cyclic AMP. This leads to an increase in cyclic AMP levels, which can then activate protein kinase A and inhibit the production of pro-inflammatory cytokines. The safety profile of ITI-214 has been evaluated in clinical studies involving humans with osteoarthritis and rheumatoid arthritis. The drug was well tolerated and did not produce any serious adverse events. ITI-214 also has other physiological functions, including the enhancement of locomotor activity and blood pressure control.

Formula: C₂₉H₂₉FN₇O₅P

Purity: Min. 95%

Molecular weight: 605.56 g/mol

Ref: 3D-SQC30338